Fundraising Fox

Boundless Bio

NASDAQ: BOLD

La Jolla, US · Founded 2018 · Delaware corporation · 3 known investors

boundlessbio.com ↗

Boundless Bio develops precision oncology medicines targeting ecDNA-amplified cancers, specifically creating a new category of ecDNA-directed therapies for patients with oncogenic alterations.

BiotechMedical Devicesin /boundlessbio@BoundlessBio

Founders & leadership

BC
Benjamin Cravatt, Ph.D.Director
HS
Ho Sung Cho, Ph.D.Director
KB
Kristina BurowDirector
CN
Carolyn Ng, Ph.D.Director
JL
Jakob Loven, Ph.D.Director
ZD
Zachary D. HornbyExecutive Officer, Director
JE
Jonathan E. Lim, M.D.Director

Investors · 3

ARCH Venture PartnersChicago · $50K – $250Mvia Kristina Burow · board
Nextech InvestZurich · $648K – $3.2M
RA CapitalBoston

Reported raises · per SEC filings

Form D private placements
▶$100MraisedAug 2023 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary D. HornbyDirector, Executive Officer
  • Benjamin Cravatt, Ph.D.Director
  • Fabio Pucci, Ph.D.Director
  • Jakob Loven, Ph.D.Director
  • Jennifer LewDirector
  • Christine Brennan, Ph.D.Director
  • Jonathan Lim, M.D.Director
  • Kristina BurowDirector
Offering amount
$100M
Amount sold
$100M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$105.6MraisedMay 2021 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin Cravatt, Ph.D.Director
  • Ho Sung Cho, Ph.D.Director
  • Kristina BurowDirector
  • Carolyn Ng, Ph.D.Director
  • Jakob Loven, Ph.D.Director
  • Zachary D. HornbyExecutive Officer, Director
  • Jonathan E. Lim, M.D.Director
Offering amount
$105.6M
Amount sold
$105.6M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.2MraisedMar 2020 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin Cravatt, Ph.D.Director
  • Scott Moorefield, Ph.D.Director
  • Chris Hassig, Ph.D.Director
  • Jason Christiansen, Ph.D.Director
  • Carolyn Ng, Ph.D.Director
  • Jonathan E. Lim, M.D.Director
  • Kristina BurowDirector
  • Ho Sung Cho, Ph.D.Director
  • Zachary D. HornbyExecutive Officer, Director
Offering amount
$52.5M
Amount sold
$23.2M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.